Related references
Note: Only part of the references are listed.The Genetic Basis of Vitiligo
Richard A. Spritz et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Efficacy of combination therapy of narrowband-ultraviolet B phototherapy or excimer laser with topical tacrolimus for vitiligo: An updated systematic review and meta-analysis
Hua-Ching Chang et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2021)
The efficacy and safety of tacrolimus as mono- and adjunctive therapy for vitiligo: A systematic review of randomised clinical trials
Charan Jeet Arora et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2020)
The relationship between stress and vitiligo: Evaluating perceived stress and electronic medical record data
Steven W. Henning et al.
PLOS ONE (2020)
Technological advances for the detection of melanoma
Lauren Fried et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Dermoscopic and Clinical Response Predictor Factors in Nonsegmental Vitiligo Treated with Narrowband Ultraviolet B Phototherapy: A Prospective Observational Study
Enzo Errichetti et al.
DERMATOLOGY AND THERAPY (2020)
Vitiligo: Targeted Therapies Add Color to Disease Pathophysiology
Khaled Ezzedine et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
David Rosmarin et al.
LANCET (2020)
Side-by-Side Comparison of Skin Biopsies and Skin Tape Stripping Highlights Abnormal Stratum Corneum in Atopic Dermatitis
Byung Eui Kim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases
Ankita Nandi et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Heme Oxygenases: Cellular Multifunctional and Protective Molecules against UV-Induced Oxidative Stress
ShiDa Chen et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
RNA-seq Reveals Dysregulation of Novel Melanocyte Genes upon Oxidative Stress: Implications in Vitiligo Pathogenesis
Konduru Seetharama Sastry et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Fine-mapping analysis of the MHC region for vitiligo based on a new Han-MHC reference panel
Chao Yang et al.
GENE (2018)
Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B
Deep Joshipura et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Repigmentation in vitiligo: position paper of the Vitiligo; Global Issues Consensus Conference
Emily Y. Gan et al.
PIGMENT CELL & MELANOMA RESEARCH (2017)
Photolichenoid papules within vitiligo induced by narrowband UVB phototherapy
M. AlJasser et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study
Liza Gill et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Polymorphism of the E-cadherin gene CDH1 is associated with susceptibility to vitiligo
Roberto Gomes Tarle et al.
EXPERIMENTAL DERMATOLOGY (2015)
Tofacitinib Citrate for the Treatment of Vitiligo A Pathogenesis-Directed Therapy
Brittany G. Craiglow et al.
JAMA DERMATOLOGY (2015)
Vitiligo
Mauro Picardo et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo
Mehdi Rashighi et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Provoking factors, including chemicals, in Dutch patients with vitiligo
C. Vrijman et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Comorbidities Associated with Vitiligo: A Ten-Year Retrospective Study
Vaneeta M. Sheth et al.
DERMATOLOGY (2013)
A central role for inducible heat-shock protein 70 in autoimmune vitiligo
Jeffrey A. Mosenson et al.
EXPERIMENTAL DERMATOLOGY (2013)
Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: A randomized intra-individual open comparative trial
Haldar S. Satyanarayan et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2013)
Association Analyses Identify Three Susceptibility Loci for Vitiligo in the Chinese Han Population
Xian-Fa Tang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference
K. Ezzedine et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
Transcriptome Analysis Reveals Markers of Aberrantly Activated Innate Immunity in Vitiligo Lesional and Non-Lesional Skin
Richard Yu et al.
PLOS ONE (2012)
Vitiligo: A comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up
Ali Alikhan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study
E. J. Nordal et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Platelet-derived Growth Factor Receptor Alpha Gene Mutations in Vitiligo Vulgaris
Shengxin Xu et al.
ACTA DERMATO-VENEREOLOGICA (2010)
Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC
Cheng Quan et al.
NATURE GENETICS (2010)
Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo.
Ying Jin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus
Z. A. Taher et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: A double-blind, placebo-controlled clinical trial
Iraj Esfandiarpour et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2009)
The burden of vitiligo: Patient characteristics associated with quality of life
May W. Linthorst Homan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Vitiligo
Alain Taieb et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genetic Variation of Promoter Sequence Modulates XBP1 Expression and Genetic Risk for Vitiligo
Yunqing Ren et al.
PLOS GENETICS (2009)
Characteristics of patients with universal vitiligo and health-related quality of life
May W. Linthorst Homan et al.
ARCHIVES OF DERMATOLOGY (2008)
Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients
D. Fai et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2007)
NALP1 in vitiligo-associated multiple autoimmune disease
Ying Jin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Analysis of RNA recovery and gene expression in the epidermis using non-invasive tape stripping
Rita Wong et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2006)
Psychosocial effects of vitiligo
K Ongenae et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2006)
Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites
T. S. Anbar et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2006)
Parametric modeling of UV-B of narrowband phototherapy for vitiligo using a novel quantitative tool - The vitiligo area scoring index
I Hamzavi et al.
ARCHIVES OF DERMATOLOGY (2004)
Topical tacrolimus for repigmentation of vitiligo
PE Grimes et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Psychiatric morbidity in vitiligo and psoriasis: A comparative study from India
SK Mattoo et al.
JOURNAL OF DERMATOLOGY (2001)